Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum.
about
Transferrin receptor 2 is frequently and highly expressed in glioblastomasThe intracellular trafficking pathway of transferrin.Hereditary hemochromatosis and transferrin receptor 2Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells.Liver iron transportPharmacokinetics and brain uptake of an IgG-TNF decoy receptor fusion protein following intravenous, intraperitoneal, and subcutaneous administration in miceMolecular regulation of hepatic expression of iron regulatory hormone hepcidin.A general map of iron metabolism and tissue-specific subnetworks.Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species.The Cytoplasmic domain of transferrin receptor 2 dictates its stability and response to holo-transferrin in Hep3B cells.Transferrin receptor 2 protein is not expressed in normal erythroid cellsA comparative study of transfection efficiency between liposomes, immunoliposomes and brain-specific immunoliposomes.Type 3 hemochromatosis and beta-thalassemia trait.Transferrin receptor 2 mediates a biphasic pattern of transferrin uptake associated with ligand delivery to multivesicular bodies.Elevated levels of transferrin receptor 2 mRNA, not transferrin receptor 1 mRNA, are associated with increased survival in acute myeloid leukaemia.Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier.Transferrin receptor 2 is emerging as a major player in the control of iron metabolism
P2860
Q33760612-431C793A-98DD-4A99-A094-D1AC1D2C82C8Q34038954-273B5E07-B18A-4157-B61E-D2AF8EFCE620Q35603164-A8EC8487-88EF-49EB-BBFD-F7E85001AF3EQ35749239-7BEC3E9C-C5BB-4D43-82B0-34A68CA0611AQ36177913-B8BDD2B6-C8D8-45F6-B9AB-F5EEB96BF6B8Q36736227-614678CA-24AD-4B41-9E82-B10BC646D0C8Q36845145-148FFC4C-E723-40A9-97BC-A0A057D56DF5Q37187218-46D0453E-7BF7-4371-A549-38CFF069B706Q38191445-B7874129-6288-47AF-AB3A-8D3AE4612ACFQ39926217-66EF2915-8929-4BAC-89B6-347CE24EE3D7Q40187430-1C50ABC7-751A-4636-98C1-CD2B0A854060Q40567010-9586DE9D-0E7F-4F2A-A8DC-AFB239328F16Q43493317-2BA4F386-1BD5-4FBA-878F-890D98F923C7Q44826224-CE6BAEB7-8B05-45CF-B7F1-229033064000Q45294458-44427A06-7B85-492C-9393-C99D8784F68AQ47965337-234A93AA-3064-4A8C-BEED-53EC2C604128Q48867737-9D108B0E-F930-45F5-92A5-718D86392B8DQ57375964-E075D9FE-A52D-4481-8CEE-A1C3D8DC48B0
P2860
Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Structural, functional, and ti ...... es and a polyclonal antiserum.
@ast
Structural, functional, and ti ...... es and a polyclonal antiserum.
@en
Structural, functional, and ti ...... es and a polyclonal antiserum.
@nl
type
label
Structural, functional, and ti ...... es and a polyclonal antiserum.
@ast
Structural, functional, and ti ...... es and a polyclonal antiserum.
@en
Structural, functional, and ti ...... es and a polyclonal antiserum.
@nl
prefLabel
Structural, functional, and ti ...... es and a polyclonal antiserum.
@ast
Structural, functional, and ti ...... es and a polyclonal antiserum.
@en
Structural, functional, and ti ...... es and a polyclonal antiserum.
@nl
P2093
P50
P1433
P1476
Structural, functional, and ti ...... es and a polyclonal antiserum.
@en
P2093
Andrea Capobianco
Angelita Calì
Clara Camaschella
Federica Alberti
Francesca Bellora
Silvia Deaglio
P304
P356
10.1182/BLOOD-2002-01-0076
P407
P577
2002-07-05T00:00:00Z